C
Chimeron Bio
Philadelphia, United States
Founded 2022
About
Chimeric viral vectors for improved gene therapy delivery
Company Details
- Type
- commercial
- Employees
- 30+
- Funding
- $50M+
Key Products
- Chimeric AAVs
- Gene Therapy
Chimeric viral vectors for improved gene therapy delivery